Results 101 to 110 of about 2,720,518 (226)

Differential Diagnosis of Primary and Secondary Hyperparathyroidism Caused by Vitamin D Deficiency

Mìžnarodnij Endokrinologìčnij Žurnal, 2015
Causes of secondary increase of parathyroid hormone, especially vitamin D deficiency, can significantly interfere with the diagnosis of hyperparathyroidism.
S.M. Cherenko, H.V. Bandura
doaj   +1 more source

Persistent Primary Hyperparathyroidism Secondary to an Ectopic Mediastinal Adenoma in a Young Adult: A Case Report. [PDF]

J ASEAN Fed Endocr Soc, 2023
Nievera KH, Alba R.
europepmc   +1 more source

Treatment of secondary hyperparathyroidism in kidney disease: what we know and do not know about use of calcimimetics and vitamin D analogs

, 2008
James B Wetmore1, L Darryl Quarles1,21Department of Medicine, Division of Nephrology, University of Kansas Medical Center, Kansas City, KS, USA; 2The Kidney Institute, University of Kansas Medical Center, Kansas City, KS, USAAbstract: There is a growing ...
James B Wetmore, L Darryl Quarles
core  

A Clinically Aligned Two‐Stage Machine Learning Framework for Predicting Hungry Bone Syndrome After Parathyroidectomy

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 5, September 2026.
A clinically aligned two‐stage machine learning framework integrates preoperative and perioperative features to predict hungry bone syndrome after parathyroidectomy. Explainable risk stratification may support individualised calcium management and early intervention for high‐risk patients.
Shih‐Min Yin, Yu‐Chieh Lin, Tzu‐Hsun Hung, Shen‐En Chou, Shun‐Yu Chi, Fong‐Fu Chou, Yi‐Ju Wu, Si‐Yuan Wu, Jenn‐Jier James Lien, Po‐Chih Kuo, Yi‐Chia Chan   +10 more
wiley   +1 more source

Sodium Intake and Osteoporosis Risk: Evidence From NHANES and Mendelian Randomization Analysis

Food Science &Nutrition, Volume 14, Issue 9, September 2026.
This study combined cross‐sectional data from the National Health and Nutrition Examination Survey (NHANES) with Mendelian Randomization (MR) analysis to systematically investigate the relationship between sodium intake and osteoporosis. The results showed that within a specific intake range (> 6150 mg/day), sodium intake was significantly negatively ...
Yunxiao Ji, Zibo Fan, Rugang Zhao, Changsong Zhao, Qiang Zhang, Xinbao Wu   +5 more
wiley   +1 more source

[Secondary hyperparathyroidism].

Chirurgia (Bucharest, Romania : 1990), 1996
Secondary (renal) hyperparathyroidism appears in chronic renal failure, sometimes in patients on chronic dialysis. Other causes includes rickets and osteomalacia. These diseases are associated with poor calcium and vitamin D absorbtion from the small bowel.
M R, Diaconescu, I, Costea, R, Terinte, S, Diaconescu, M, Covic, E, Zbranca   +5 more
openaire   +1 more source

Hypercalcemia in a Patient With Spinal Tuberculosis and Aspergillus Co‐Infection: A Case‐Report

Immunity, Inflammation and Disease, Volume 14, Issue 9, September 2026.
ABSTRACT Background Tuberculosis (TB), one of the leading infectious causes of mortality worldwide, may disseminate hematogenously and result in extrapulmonary manifestations. Spinal tuberculosis (ST) is an uncommon but serious form of extrapulmonary TB.
Negin Parsa, Amirpasha Amlelshahbaz, Hamidreza Soltani   +2 more
wiley   +1 more source

Persistent hyperparathyroidism secondary to ectopic parathyroid adenoma in lung: Case report. [PDF]

Front Endocrinol (Lausanne), 2022
Valizadeh M, Ebadinejad A, Amouzegar A, Zakeri A.   +3 more
europepmc   +1 more source

Musculoskeletal Outcomes of Glucagon‐Like Peptide‐1 Receptor Agonists Versus Other Antiobesity Agents in Nondiabetic Adults

Obesity, Volume 34, Issue S2, Page 119-131, September 2026.
ABSTRACT Objective This study aimed to evaluate the association of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) with risks of osteoporosis, major osteoporotic fractures, and degenerative musculoskeletal disorders in nondiabetic adults with obesity compared with other obesity medications.
Jie‐Syuan Wu, Lee‐Yuan Lin, Jia‐Wei Sun, Wei‐Ting Yu, Fara Silvia Yuliani, Shyh‐Hsiang Lin   +5 more
wiley   +1 more source

Cost-effectiveness analysis of cinacalcet vs. paricalcitol in the treatment of hyperparathyroidism secondary to chronic kidney disease. [PDF]

J Bras Nefrol, 2023
Ponce D, Cardoso MMA, Rúgolo JRM, Molina SA, Andrade LGM, Curado DDSP.   +5 more
europepmc   +1 more source